Performance analysis of Redhill Biopharma (RDHL)
Annual Return
Over the past 3 years, RDHL has had an average annual return of -68.23%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, RDHL has had an average annual return of -82.69%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, RDHL has had an average annual return of -60.56%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jan 7, 2013, RDHL has had an average annual return of -49.34%, underperforming the benchmark SPY, which returned +14.77% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -83.33% | -81.82% | -73.81% | -94.58% | -68.07% | +33.12% | +9.36% | +7.97% | -50.85% | -18.80% | -3.37% |
| 2014 | 2013 | ||||||||||
| +12.96% | +6.31% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | |||||
| 2025 | -16.67% | -40.00% | -33.33% | +0% | +0% | +0% | -50.00% | +0% | +100% | -50.00% | +0% | +0% | -83.33% |
| 2024 | -60.61% | +7.69% | -14.29% | -16.67% | +0% | -20.00% | +12.50% | -11.11% | +0% | -12.50% | +14.29% | -25.00% | -81.82% |
| 2023 | +55.56% | +4.08% | -54.90% | -40.22% | -5.45% | -48.08% | +7.41% | -31.03% | -45.00% | -9.09% | +350% | -26.67% | -73.81% |
| 2022 | +1.94% | -16.72% | +15.05% | -32.91% | -33.75% | -22.30% | +0% | +3.32% | -44.07% | +38.41% | -48.33% | -61.11% | -94.58% |
| 2021 | +4.22% | +12.83% | -22.95% | -6.84% | +6.32% | -5.11% | -6.39% | +56.83% | -54.65% | +18.78% | -46.32% | -11.67% | -68.07% |
| 2020 | -12.84% | -21.93% | +9.67% | +58.49% | -0.83% | -5.89% | +18.36% | +4.16% | +23.73% | -18.19% | +5.74% | -8.60% | +33.12% |
| 2019 | +49.54% | -7.94% | +8.76% | -5.41% | -5.72% | -12.28% | +1.84% | +14.50% | -7.13% | -4.81% | +2.22% | -11.39% | +9.36% |
| 2018 | +21.01% | +3.53% | -20.03% | -5.84% | +47.22% | +19.48% | -8.91% | -3.73% | +18.04% | -10.65% | +6.60% | -34.01% | +7.97% |
| 2017 | -6.59% | -1.84% | +0% | +4.90% | -6.76% | -8.09% | +14.04% | -12.31% | +25.41% | -17.49% | -43.49% | +1.98% | -50.85% |
Drawdown analysis of Redhill Biopharma (RDHL)
The maximum drawdown for the RDHL was -99.99%, occurring on Jul 28, 2025. This drawdown has not yet recovered.
The current RDHL drawdown is -99.99%.
Since Jan 7, 2013 RDHL has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Jun 16, 2015 | 2543 | Jul 28, 2025 | Ongoing | Ongoing | Ongoing |
| -58.18% | Jun 12, 2014 | 110 | Nov 17, 2014 | 144 | Jun 16, 2015 | 254 |
| -38.90% | Jan 31, 2013 | 108 | Jul 8, 2013 | 133 | Jan 15, 2014 | 241 |
| -8.79% | Jan 17, 2014 | 9 | Jan 31, 2014 | 18 | Feb 27, 2014 | 27 |
| -5.90% | Apr 3, 2014 | 10 | Apr 17, 2014 | 18 | May 14, 2014 | 28 |
| -5.17% | Jan 18, 2013 | 2 | Jan 23, 2013 | 6 | Jan 31, 2013 | 8 |
| -3.77% | May 28, 2014 | 1 | May 29, 2014 | 8 | Jun 10, 2014 | 9 |
| -3.62% | Feb 27, 2014 | 3 | Mar 4, 2014 | 6 | Mar 12, 2014 | 9 |
| -3.44% | Mar 12, 2014 | 8 | Mar 24, 2014 | 6 | Apr 1, 2014 | 14 |
| -2.93% | Jan 15, 2014 | 1 | Jan 16, 2014 | 1 | Jan 17, 2014 | 2 |
| -0.81% | May 22, 2014 | 1 | May 23, 2014 | 1 | May 27, 2014 | 2 |
| -0.43% | May 20, 2014 | 1 | May 21, 2014 | 1 | May 22, 2014 | 2 |